|
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) (USD $)
|
3 Months Ended | 6 Months Ended | 47 Months Ended | ||
|---|---|---|---|---|---|
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
|
| Condensed Consolidated Statements Of Operations And Comprehensive Loss | |||||
| Revenue | $ 54,968 | ||||
| Expenses | |||||
| General and administrative | 51,757 | 123,143 | 120,668 | 174,699 | 1,269,896 |
| Professional fees | 165,901 | 92,394 | 293,022 | 157,359 | 1,929,576 |
| Salaries and office administrative fees | 41,485 | 191,315 | 213,163 | 389,392 | 2,323,757 |
| Research and development | 791,294 | 640,639 | 1,661,758 | 1,233,838 | 8,631,895 |
| Impairment of patents | 350,000 | ||||
| Total Operating Expenses | 1,050,437 | 1,047,491 | 2,288,611 | 1,955,288 | 14,505,124 |
| Net Operating Loss | (1,050,437) | (1,047,491) | (2,288,611) | (1,955,288) | (14,450,156) |
| Other Income | |||||
| Grants received | 143,987 | 1,009,610 | |||
| Gain on derivative remeasurement | 1,867,241 | 767,001 | 767,001 | ||
| Other Income | 1,867,241 | 910,988 | 1,776,611 | ||
| Provision for income taxes | |||||
| Net Income (Loss) | 816,804 | (1,047,491) | (1,377,623) | (1,955,288) | (12,673,545) |
| Other Comprehensive Loss | |||||
| Foreign currency translation adjustments | (9,642) | (12,871) | (13,838) | (11,858) | (73,633) |
| Total Other Comprehensive Loss | (9,642) | (12,871) | (13,838) | (11,858) | (73,633) |
| Net Comprehensive Income (Loss) | $ 807,162 | $ (1,060,362) | $ (1,391,461) | $ (1,967,146) | $ (12,747,178) |
| Net Income (Loss) per Share - Basic | $ 0.06 | $ (0.1) | $ (0.11) | $ (0.19) | |
| Net Income (Loss) per Share - Diluted | $ 0.06 | $ (0.1) | $ (0.11) | $ (0.19) | |
| Weighted Average Shares Outstanding - Basic | 13,388,050 | 10,642,175 | 12,821,421 | 10,427,414 | |
| Weighted Average Shares Outstanding - Diluted | 13,887,997 | 10,642,175 | 12,821,421 | 10,427,414 | |
| X | ||||||||||
|
- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax of other comprehensive income (loss) attributable to parent entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Gain on derivative remeasurement. No definition available.
|
| X | ||||||||||
|
- Definition
Grants Received No definition available.
|